EQT Life Sciences — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Amolyt Pharmaamolytpharma.comSeries B · Sep 2021 · $80M
Co-investorsAndera PartnersCTI Life Sciences Fund L.P.Kurma PartnersLSP (Life Sciences Partners)Sofinnova Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Egle Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.